Marnie Peterson works on characterization of interactions between microbes such as Staphylococcus aureus and mucosal surfaces for the development of novel drug therapies including topical microbicides, anti-inflammatory agents as well as mucosal vaccine strategies. Learn more about Dr. Peterson's work by reading International Innovation-Healthcare's "Tackling Staphylococcal exotoxins" (PDF).

She also looks a staphylococcal pathogenesis for the treatment and prevention of Staphylococcal Infections & Toxic Shock Syndrome. Staphylococcal exoproteins (hemolysins and superantigens) activate pro-inflammatory mechanisms of epithelial cells, which promotes toxin-mediated diseases Development of a Topical Microbicides: dual acting antimicrobial and antiinflammatory agents for treatment of infections and promotion of wound healing.

Experience

  • –present
    Associate Professor in Experimental and Clinical Pharmacology, University of Minnesota

Contact Marnie for

  • General
  • Media request
  • Speaking request
  • Consulting / Advising
  • Research collaboration
  • Research supervision